The pups, some as young as eight months, were “reused” and then “euthanized” if they suffered organ dysfunction, were infected or became weak.

Merck KGaA is filing for global regulatory approvals of pimicotinib after it met primary and secondary endpoints in a Phase ...

Notably, the U.S.’ two primary biopharma trade groups—the Pharmaceutical Research and Manufacturers of America (PhRMA) and ...

Under the deal, announced on May 20, Pfizer gains the opportunity to develop and sell the SSGJ-707 drug in markets outside of ...

Keros Therapeutics, a biotech currently engaged in a public fight with one of its largest shareholders over the future ...

In 2025, A-share tech-focused ETFs have continued to attract significant investor interests - the top five industry/thematic ...

In a letter to the Department of Commerce, Novo Nordisk argued that unsanctioned compounded semaglutide, mostly from China, ...

In this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical ...

Nearly a third of employed and almost half of unemployed BioSpace survey respondents are seriously considering leaving the ...

China is now setting the pace in life sciences R&D, conducting more clinical trials than the U.S. and licensing new ...

Western drugmakers, investors increasingly aim to acquire Chinese compounds.